Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H(HK:1276)
HK$50.55-0.40 (-3.16%)
HK:1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H financials statements
HK$50.55
At close:-0.40 (-3.16%)
Want to see HK:1276 full AI Analyst Report?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Financial Statements
9 Followers
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H Financial Overview
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H's market cap is currently HK$375.15B. The company's EPS TTM is HK$1.53; its P/E ratio is 35.96; and it has a dividend yield of 0.45%. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | HK$ 35.19B | HK$ 29.77B | HK$ 25.26B | HK$ 24.23B | HK$ 31.02B |
| Gross Profit | HK$ 30.33B | HK$ 25.68B | HK$ 21.36B | HK$ 20.26B | HK$ 26.20B |
| Operating Income | HK$ 10.00B | HK$ 7.97B | HK$ 5.43B | HK$ 4.68B | HK$ 4.54B |
| EBITDA | HK$ 10.63B | HK$ 8.46B | HK$ 5.95B | HK$ 5.19B | HK$ 5.19B |
| Net Income | HK$ 8.58B | HK$ 6.74B | HK$ 4.76B | HK$ 4.45B | HK$ 5.46B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | HK$ 45.69B | HK$ 26.69B | HK$ 22.95B | HK$ 20.06B | HK$ 22.90B |
| Total Assets | HK$ 77.73B | HK$ 53.33B | HK$ 48.21B | HK$ 47.57B | HK$ 48.03B |
| Total Debt | HK$ 48.18M | HK$ 73.44M | HK$ 692.54M | HK$ 1.91B | HK$ 1.36B |
| Net Debt | HK$ -45.51B | HK$ -26.33B | HK$ -22.15B | HK$ -15.06B | HK$ -15.31B |
| Total Liabilities | HK$ 8.98B | HK$ 4.30B | HK$ 2.99B | HK$ 4.31B | HK$ 4.38B |
| Stockholders' Equity | HK$ 68.17B | HK$ 48.42B | HK$ 44.55B | HK$ 42.47B | HK$ 42.82B |
| Cash Flow | |||||
| Free Cash Flow | HK$ 9.20B | HK$ 5.80B | HK$ 6.82B | HK$ -827.89M | HK$ 3.39B |
| Operating Cash Flow | HK$ 12.50B | HK$ 7.90B | HK$ 8.46B | HK$ 1.44B | HK$ 5.40B |
| Investing Cash Flow | HK$ -3.05B | HK$ -2.03B | HK$ 1.35B | HK$ 444.51M | HK$ -559.25M |
| Financing Cash Flow | HK$ 8.66B | HK$ -1.65B | HK$ -3.48B | HK$ -363.05M | HK$ -1.62B |
Currency in HKD
